New Enterprise Associates related stories
All articles and analysis
Bra maker ThirdLove snaps up $8 mlnThirdLove, a maker of bras, has raised $8 million in Series A funding. New Enterprise Associates led the round.
IPO Aftermarket: Nutanix, others wait in registration as IPOs dropIn 2015, only 72 VC-backed IPOs were launched, 75 percent of which were in biotech, medical or healthcare-related fields
- Claudia Fan Munce leaves IBM to join NEA
Claudia Fan Munce, a long-time fixture in the venture group of IBM, has joined New Enterprise Associates as a venture advisor.
- BloomReach grabs $56 mln Series D
Mountain View, California-based BloomReach, a cloud personalization platform provider, has raised $56 million in Series D funding. The investors included Bain Capital Ventures, Battery Ventures, Lightspeed Ventures, New Enterprise Associates and Salesforce Ventures. In addition to the funding, the company has named Marcus Ryu, CEO and co-founder of Guidewire Software, to its board of directors.
- VC-backed Surface Oncology appoints chief scientific officer
Cambridge, Massachusetts-based Surface Oncology Inc, a developer of next-generation cancer immunotherapies, has named Dr. Vito J. Palombella as chief scientific officer. Previously, Palombella worked at Infinity Pharmaceuticals where he served as executive vice president and chief scientific officer. Surface's backers include Atlas Venture, Lilly Ventures and New Enterprise Associates.
Giving insurance its dueStartups focused on healthcare and car insurance for consumers are drawing interest from VCs, who see a trillion-dollar industry ripe for disruption
- Tarveda Therapeutics scores $38 mln Series C
Tarveda Therapeutics (formerly known as Blend Therapeutics) has raised $38 million in Series C funding. Novo A/S and return backer New Enterprise Associates led the round. The other investors included Flagship Ventures, NanoDimension and Eminent Venture Capital. In conjunction with the financing, Nilesh Kumar of Novo Ventures (US) Inc. and Dr. Frank Torti of NEA have been added to Tarveda’s board of directors while Drew Fromkin has been appointed interim board chairman.Watertown, Massachusetts-based Tarveda is a biopharmaceutical company focused on treating patients with solid tumor cancers.
- VC-backed Euclid Analytics hires sales and business development SVP
Euclid Analytics, which provides customer location analytics, has named Brennan O'Donnell as senior vice president of sales and business development. Previously, O'Donnell worked at SurveyMonkey where he was the vice president of sales and customer success. Euclid is backed by Benchmark Capital, New Enterprise Associates, Cox Enterprises and Groupe Arnault.
- Founders Fund leads Series B funding of Branch Metrics
Palo Alto, Calif.-based Branch Metrics, which develops “deep linking” technology to allow mobile users to discover and share apps and app content, announced it has raised $35 million in a Series B funding round led by new investor Founders Fund. Existing investors participating in the round include New Enterprise Associates, Pejman Mar Ventures, Cowboy Ventures and individuals Zach Coelius and Ben Narasin (now a partner at Canvas Ventures). New investor Madrona Venture Group also took part in the round, which brings the company’s total funding to $53 million. As part of the round, Scott Nolan, a partner at Founders Fund, has joined the board.
Carried away in ViennaSpeedinvest’s $100 million final close has vindicated the seed investor’s work-for-equity model, which ditches carried interest for hands-on roles at portfolio companies